• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, August 12, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

HMSOM researchers: Data shows clinical trials becoming more inclusive

Bioengineer by Bioengineer
February 2, 2024
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Clinical trials and medical research have been historically lacking in diversity among all groups.

Hackensack Meridian School of Medicine

Credit: Hackensack Meridian Health

Clinical trials and medical research have been historically lacking in diversity among all groups.

But recent trends have been turning the tide at least a little bit toward equity and inclusivity, according to a new meta-analysis published by a team of investigators from the Hackensack Meridian School of Medicine (HMSOM) and the Hackensack Meridian Health Research Institute (HMHRI).

The meta-analysis of clinical trials which included New Jersey patients from 2017 to 2022 show a snapshot of more diverse representation – and better reporting of race and ethnicity factors, according to the new paper in the Elsevier journal Global Epidemiology.

“The past five years have seen an overall uptick in the equity of race/ethnicity reporting and inclusivity of clinical trials, as compared to previously reported data, presaging the potential acquisition of ever more powerful and meaningful results of such intervention studies going forward,” write the authors, including three HMSOM students.

The team used the Clinicaltrials.gov registry to identify nearly 500 clinical trials which took place at least in part in New Jersey.

Of this group of trials, greater than 97 percent reported on race and/or the ethnicity of the enrollees, according to the findings. The participation in the trials assessed collectively still showed a majority 76.7 percent White participants; but the Black participants made up about 14.1 percent of the enrollees, which is slightly higher than the 2020 U.S. Census figure (which was used as a reference standard.)

The proportion of Asian and Hispanic descent, however, was slightly lower than the corresponding Census figures.

Thus, more inclusivity work needs to be done, according to the authors.

“Our 5-year snapshot reveals that a very large percentage of trials report on race/ethnicity – and inclusivity is improving,” the authors conclude. “While there is still some way to go to have the demographic numbers in these trials match U.S. Census values, our results suggest that recent efforts are having an effect.”



Journal

Global Epidemiology

DOI

10.1016/j.gloepi.2023.100134

Method of Research

Data/statistical analysis

Subject of Research

Not applicable

Article Title

Improved clinical trial race/ethnicity reporting and updated inclusion profile, 2017–2022: A New Jersey snapshot

Article Publication Date

11-Jan-2024

COI Statement

The authors declare no competing/conflicting interests.

Share12Tweet8Share2ShareShareShare2

Related Posts

blank

DFG Funds Enhanced Reliability in Evaluations of Statistical Methods

August 12, 2025
Glutamatergic Synapses Resist Human Alpha-Synuclein Overexpression

Glutamatergic Synapses Resist Human Alpha-Synuclein Overexpression

August 12, 2025

Advancing Cancer Care: The Promise of Antitumor mRNA-Based Vaccines in Personalized Treatment

August 12, 2025

Embryonic Factors Reverse ALS Damage in Motor Neurons

August 12, 2025

POPULAR NEWS

  • blank

    Molecules in Focus: Capturing the Timeless Dance of Particles

    140 shares
    Share 56 Tweet 35
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    78 shares
    Share 31 Tweet 20
  • Modified DASH Diet Reduces Blood Sugar Levels in Adults with Type 2 Diabetes, Clinical Trial Finds

    57 shares
    Share 23 Tweet 14
  • Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    61 shares
    Share 24 Tweet 15

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

BTI, Meiogenix, and FFAR Launch $2 Million Collaborative Project to Advance Tomato Genetics

DFG Funds Enhanced Reliability in Evaluations of Statistical Methods

Kennesaw State Physics Professor Awarded Three-Year Grant to Develop Particle Collider Simulations

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.